These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 15559137)

  • 1. [Effect of the heparin-lysine complex on the hemostatic and insular systems].
    Ul'ianov AM; Liapina LA; Pastorova VE; Obergan TIu; Shubina TA
    Izv Akad Nauk Ser Biol; 2004; (5):581-4. PubMed ID: 15559137
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Changes in the functional status of the hemostatic system with the administration of heparin combined with aspirin to animals with experimental diabetes].
    Liapina LA; Pastorova VE; Ul'ianov AM; Tarasov IuA
    Izv Akad Nauk Ser Biol; 1996; (5):624-7. PubMed ID: 9004901
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Antidiabetic properties of high molecular weight heparin-adenosine triphosphate complex].
    Ul'ianov AM; Liapin LA; Pastorova VE
    Izv Akad Nauk Ser Biol; 2006; (1):77-80. PubMed ID: 16521542
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effect of a peony root preparation on the status of the insulin and hemostatic system in animals during development of alloxan diabetes].
    Ul'ianov AM; Tarasov IuA; Liapina LA; Pastorova VE; Uspenskaia MS
    Vopr Med Khim; 1998; 44(3):256-61. PubMed ID: 9703625
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Effect of heparin combined with aspirin upon intragastric administration on the state of the insulin system in animals with alloxan diabetes].
    Ul'ianov AM; Tarasov IuA; Liapina LA
    Izv Akad Nauk Ser Biol; 1995; (3):372-5. PubMed ID: 7670355
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Insulin-heparin complex, its physiological properties].
    Kudriashov BA; Pytel' IuA; Liapina LA; Baskakova GM
    Vopr Med Khim; 1981; 27(4):547-52. PubMed ID: 7027617
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Heparin concentration and hemostatic alterations with low systemic heparinization during CPB using heparin-coated circuits].
    Yoshie M; Hirose Y; Gamo M; Matsuo K
    Masui; 2001 Feb; 50(2):179-83. PubMed ID: 11244775
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The effect of the joint administration of heparin and chitosan sulfate ether on hemostatic function].
    Drozd NN; Makarov VA; Bashkov GV; Gal'braĭkh LS; Vikhoreva GA; Gorbacheva IN
    Eksp Klin Farmakol; 1996; 59(1):30-3. PubMed ID: 8704629
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Antidiabetic and anticoagulant properties of the heparin-glutamic acid complex].
    Ul'ianov AM; Liapina LA; Pastorova VE; Smolina TIu
    Izv Akad Nauk Ser Biol; 2004; (3):340-4. PubMed ID: 15354961
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effect of chronic intramuscular administration of low molecular weight heparin-collagen complex on hemostatic indices and development of alloxan-induced diabetes].
    Liapina LA; Ul'ianov AM; Pastorova VE; Obergan TIu
    Izv Akad Nauk Ser Biol; 2006; (3):381-4. PubMed ID: 16771153
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hemostatic activation under anticoagulant treatment: a comparison of unfractionated heparin vs. nadroparin in the treatment of proximal deep vein thrombosis.
    Stricker H; Marchetti O; Haeberli A; Mombelli G
    Thromb Haemost; 1999 Oct; 82(4):1227-31. PubMed ID: 10544903
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Complex compound of heparin and glutamic acid: synthesis and effect on hemostasis parameters in vitro and in vivo].
    Liapina LA; Ziadetdinova GA
    Izv Akad Nauk Ser Biol; 2001; (1):82-6. PubMed ID: 11236584
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anticoagulation management associated with extracorporeal circulation.
    Sniecinski RM; Levy JH
    Best Pract Res Clin Anaesthesiol; 2015 Jun; 29(2):189-202. PubMed ID: 26060030
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The influence of the Soviet antimalarial preparation dabequin on the hemostatic system and on the anticoagulant effect of heparin].
    Pomortseva IV; Ovchinnikova LK; Shcheglova NV
    Farmakol Toksikol; 1990; 53(1):59-62. PubMed ID: 2328805
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [A complex of heparin with the peptide Arg-Pro-Gly-Pro and its anticoagulative, fibrinolytic, and hyperglycemia effects].
    Liapina LA; Miasoedov NF; Andreeva LA; Obergan TIu; Shubina TA; Grigor'eva ME; Pastorova VE
    Izv Akad Nauk Ser Biol; 2012; (1):72-7. PubMed ID: 22567874
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The protective effect of the arginine-heparin complex under simulation of insulin-dependent diabetes].
    Ul'ianov AM; Obergan TIu; Shubina TA; Pastorova VE; Liapina LA
    Izv Akad Nauk Ser Biol; 2010; (1):109-14. PubMed ID: 20235435
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chemotherapy-induced activation of hemostasis: effect of a low molecular weight heparin (dalteparin sodium) on plasma markers of hemostatic activation.
    Weitz IC; Israel VK; Waisman JR; Presant CA; Rochanda L; Liebman HA
    Thromb Haemost; 2002 Aug; 88(2):213-20. PubMed ID: 12195692
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Anticoagulant, fibrinolytic and antithrombotic effects of the heparin-insulin complex].
    Liapina LA; Pastorova VE
    Izv Akad Nauk Ser Biol; 2002; (6):710-3. PubMed ID: 12561334
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Anticoagulation and antiaggregation in pediatrics].
    Kühne T
    Ther Umsch; 2003 Jan; 60(1):49-53. PubMed ID: 12638479
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Changes in hemostasis and vagal tonus in healthy individuals and patients with facial neuropathy by micro-dose heparin stimulation of nasal receptors].
    Uryvaev IV; Iudel'son IB; Sergeev VV
    Vestn Ross Akad Med Nauk; 1997; (8):22-3. PubMed ID: 9340043
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.